Literature DB >> 24510629

Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients.

Fabian Sanchis-Gomar1, Rafael Alis, Helios Pareja-Galeano, Eva Sola, Victor M Victor, Milagros Rocha, Antonio Hernández-Mijares, Marco Romagnoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24510629     DOI： 10.1007/s12020-014-0170-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  9 in total

1.  Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes.

Authors:  Fabian Sanchis-Gomar; Giuseppe Lippi; Sara Mayero; Carme Perez-Quilis; José L García-Giménez
Journal:  J Diabetes       Date:  2012-09       Impact factor: 4.006

2.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  The skeletal muscle-metabolism axis in prostate-cancer therapy.

Authors:  Fabian Sanchis-Gomar
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

4.  Inconsistency in circulating irisin levels: what is really happening?

Authors:  F Sanchis-Gomar; R Alis; H Pareja-Galeano; M Romagnoli; C Perez-Quilis
Journal:  Horm Metab Res       Date:  2014-01-23       Impact factor: 2.936

Review 5.  Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?

Authors:  Mark A Febbraio; Bente K Pedersen
Journal:  Exerc Sport Sci Rev       Date:  2005-07       Impact factor: 6.230

6.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

7.  Serum irisin levels in new-onset type 2 diabetes.

Authors:  Yeon-Kyung Choi; Mi-Kyung Kim; Kwi Hyun Bae; Hyun-Ae Seo; Ji-Yun Jeong; Won-Kee Lee; Jung-Guk Kim; In-Kyu Lee; Keun-Gyu Park
Journal:  Diabetes Res Clin Pract       Date:  2013-01-29       Impact factor: 5.602

8.  Irisinemia: a novel concept to coin in clinical medicine?

Authors:  Fabian Sanchis-Gomar; Carme Perez-Quilis
Journal:  Ann Nutr Metab       Date:  2013-08-08       Impact factor: 3.374

9.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962
  9 in total
  28 in total

Review 1.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

2.  Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Anastasia Margouta; Christos S Mantzoros
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

3.  Comprehensive evaluation of irisin levels in fetomaternal circulation of pregnant women with obesity or gestational diabetes mellitus.

Authors:  Ali Seven; Esin Yalinbas; Suna Kabil Kucur; Emel Kocak; Ozben Isiklar; Beril Yuksel; Hakan Timur; Mehmet Erbakirci; Nadi Keskin
Journal:  Ir J Med Sci       Date:  2019-05-17       Impact factor: 1.568

4.  FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs.

Authors:  Fabian Sanchis-Gomar; Nuria Garatachea; Zi-hong He; Helios Pareja-Galeano; Noriyuki Fuku; Ye Tian; Yasumichi Arai; Yukiko Abe; Haruka Murakami; Motohiko Miyachi; Thomas Yvert; Catalina Santiago; Letizia Venturini; Carmen Fiuza-Luces; Alejandro Santos-Lozano; Gabriel Rodríguez-Romo; Giovanni Ricevuti; Nobuyoshi Hirose; Enzo Emanuele; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2014-11-27

Review 5.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

6.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

7.  Changes of Circulating Irisin and High-Sensitivity C-Reactive Protein Levels in Morbidly Obese Individuals with Type 2 Diabetes After Roux-en-Y Gastric Bypass.

Authors:  Prapimporn Ch Shantavasinkul; Philip Omotosho; Leonor Corsino; Michael J Muehlbauer; Pairoj Chattranukulchai; Alfonso Torquati
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2022-02-11       Impact factor: 1.766

8.  Factors associated with circulating concentrations of irisin in the general population cohort of the ABCD study.

Authors:  S Buscemi; D Corleo; S Vasto; C Buscemi; M F Massenti; D Nuzzo; G Lucisano; A M Barile; G Rosafio; V Maniaci; C Giordano
Journal:  Int J Obes (Lond)       Date:  2017-10-13       Impact factor: 5.095

9.  What Is the Relationship Between Body Mass Index, Sex Hormones, Leptin, and Irisin in Children and Adolescents? A Path Analysis.

Authors:  Li Zhang; Xingwang Peng; Yuanyuan Wang; Ruiyao Cao; Zizhe Zhang; Lianguo Fu
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.569

Review 10.  Irisin: a new molecular marker and target in metabolic disorder.

Authors:  Jia-qi Chen; Yue-ye Huang; Aaron M Gusdon; Shen Qu
Journal:  Lipids Health Dis       Date:  2015-01-14       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.